688656.SS SHH
HOB Biotech Group Corp.,Ltd
1W: +12.1%
1M: +36.6%
3M: +26.6%
YTD: -7.5%
1Y: +17.7%
3Y: +288.9%
5Y: +71.8%
¥131.72 ($19.64)
-0.31 (-0.23%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$73M
-27.9% ▼
5Y CAGR: +4.6%
Capital Expenditures
$74M
+52.4% ▲
5Y CAGR: +5.3%
Free Cash Flow
-$961K
+98.2% ▲
Dividends Paid
$21M
+26.2% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$63M
-50.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $86M | $42M | $47M | $37M | $23M |
| Depreciation & Amort. | $25M | $33M | $40M | $45M | $65M |
| Stock-Based Comp. | $0 | $1M | $0 | $0 | $0 |
| Change in Working Capital | $2M | -$19M | $4M | $7M | -$17M |
| Other Non-Cash Items | -$8M | $3M | $12M | $12M | $2M |
| Operating Cash Flow | $105M | $58M | $103M | $101M | $73M |
| — Investing Activities — | |||||
| Capital Expenditures | -$168M | -$220M | -$178M | -$155M | -$74M |
| Acquisitions (Net) | $1M | $495K | $0 | $0 | $24K |
| Investment Purchases | -$1M | -$896M | -$382M | -$155M | $0 |
| Investment Sales | $12M | $771M | $519M | $156M | $0 |
| Other Investing | $1M | $1 | $1M | $548K | $23M |
| Investing Cash Flow | -$154M | -$344M | -$40M | -$154M | -$50M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$24M | $30M | -$25M | $65M | -$70M |
| Stock Repurchased | $0 | $0 | $0 | -$20M | $0 |
| Dividends Paid | -$19M | -$33M | -$21M | -$28M | -$21M |
| Other Financing | $484M | -$6M | -$7M | -$6M | $5M |
| Financing Cash Flow | $441M | -$11M | -$53M | $11M | -$86M |
| Net Change in Cash | $391M | -$297M | $10M | -$42M | -$63M |
| Cash End of Period | $450M | $153M | $163M | $122M | $59M |
| Free Cash Flow | -$63M | -$162M | -$75M | -$54M | -$961K |